Familial pseudohypoparathyroidism
| dc.authorid | 0000-0001-9532-8241 | |
| dc.authorid | 0000-0002-6423-4418 | |
| dc.contributor.author | Gürler, Müjgan | |
| dc.contributor.author | Özsarı, Levent | |
| dc.date.accessioned | 2021-06-23T19:51:25Z | |
| dc.date.available | 2021-06-23T19:51:25Z | |
| dc.date.issued | 2019 | |
| dc.department | BAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
| dc.description | World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO) -- APR 04-07, 2019 -- Paris, FRANCE | en_US |
| dc.description.abstract | [No Abstract Available] | en_US |
| dc.description.sponsorship | Int Osteoporosis Fdn, ESCEO, Mylan, UCB, IBSA, Medimaps, Lilly, Hologic, Strax Corp, Kyowa Kirin, Galgo Med, EffRx, Amgen, Abiogen Pharma, Medi, Fidia Pharma Grp, TRB Chemedica Sa, AgNovos Healthcare GmbH, Expanscience Labs, Wisepress Com, GE, Pierre Fabre, Roche, Echolight, Thuasne, Theramex, Bindex, Gedeon Richter, Sinklar Conf Management B V | en_US |
| dc.identifier.endpage | S285 | en_US |
| dc.identifier.issn | 0937-941X | |
| dc.identifier.issn | 1433-2965 | |
| dc.identifier.startpage | S285 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12491/9982 | |
| dc.identifier.volume | 30 | en_US |
| dc.identifier.wos | WOS:000475685501071 | en_US |
| dc.identifier.wosquality | Q2 | en_US |
| dc.indekslendigikaynak | Web of Science | en_US |
| dc.institutionauthor | Gürler, Müjgan | |
| dc.language.iso | en | en_US |
| dc.publisher | Springer London Ltd | en_US |
| dc.relation.ispartof | Osteoporosis International | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | [Anahtar Kelime Yok] | en_US |
| dc.title | Familial pseudohypoparathyroidism | en_US |
| dc.type | Conference Object | en_US |
